Limited durability of protection conferred by XBB.1.5 vaccines against Omicron-associated severe outcomes among community-dwelling adults aged ≥50 years, Ontario, Canada, September 2023 to June 2024
preprint
OA: closed
CC-BY-NC-4.0
Abstract
ABSTRACT We estimated XBB.1.5 vaccine effectiveness against hospitalization/death among adults aged ≥50 years. Compared with non-XBB.1.5 vaccinees, the initial protection of 64% (95%CI, 57%−69%) was reduced when JN/KP-sublineages became predominant, and quickly declined. No significant protection was observed >6 months post-vaccination. Short durability of protection poses unique challenges for COVID-19 vaccination.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-05-20T01:45:00.602351+00:00
- unpaywall
- last seen: 2026-05-26T02:00:01.498150+00:00
License: CC-BY-NC-4.0